3',4'-Methylenedioxy-α-pyrrolidinobutiophenone

3',4'-Methylenedioxy-α-pyrrolidinobutiophenone (also known as MDPBP) is a psychoactive drug and research chemical that belongs to the cathinone class. It is a stimulant and has been found to possess empathogenic effects.

History

MDPBP was first synthesized in the early 2000s as part of a wave of new psychoactive substances. It was initially sold as a designer drug in various online markets. The drug gained notoriety due to its potent stimulant effects and potential for abuse.

Chemistry

MDPBP is a phenethylamine derivative with a pyrrolidine ring attached to the alpha carbon. It also features a methylenedioxy group attached to the phenyl ring. The chemical structure of MDPBP is similar to that of other cathinones, such as MDPV and α-PVP, which are also known for their potent stimulant effects.

Pharmacology

MDPBP acts as a norepinephrine-dopamine reuptake inhibitor (NDRI), increasing the levels of these neurotransmitters in the brain. This results in increased alertness, euphoria, and a sense of increased energy and focus. However, it can also lead to side effects such as increased heart rate, hypertension, and potential for addiction.

Legal Status

The legal status of MDPBP varies by country. In many countries, it is classified as a controlled substance due to its potential for abuse and addiction. In the United States, MDPBP is a Schedule I controlled substance under the Controlled Substances Act.

Health Risks

The use of MDPBP can lead to a number of health risks. These include cardiovascular issues such as increased heart rate and blood pressure, as well as neurological issues such as anxiety, paranoia, and potential for addiction. Long-term use can lead to severe health problems, including heart disease and mental health disorders.

See Also

• Cathinone
• MDPV
• α-PVP
• Psychoactive drug
• Research chemical

3',4'-Methylenedioxy-α-pyrrolidinobutiophenone Resources
Latest articles Most recent articles Ongoing trials	Wikipedia